Ganciclovir — Active Pharmaceutical Ingredient

Ganciclovir is an active pharmaceutical ingredient found in 5 FDA-approved drug products. Forms: IMPLANT, SOLUTION, CAPSULE, GEL. Routes: IMPLANTATION, INTRAVENOUS, ORAL, OPHTHALMIC.

This content is for informational purposes only. Always consult a healthcare professional.

Ganciclovir (5 brand names, 4 dosage forms, 4 routes)

Available dosage forms: IMPLANT, SOLUTION, CAPSULE, GEL.

Routes of administration: IMPLANTATION, INTRAVENOUS, ORAL, OPHTHALMIC.

Brand Names

  • CYTOVENE
  • GANCICLOVIR
  • GANZYK-RTU
  • VITRASERT
  • ZIRGAN

Indications and Usage

ZIRGAN is indicated for the treatment of acute herpetic keratitis (dendritic ulcers) in adults and pediatric patients aged 2 years and older.

Dosage and Administration

The recommended dosage is 1 drop in the affected eye 5 times per day (approximately every 3 hours while awake) until the corneal ulcer heals, and then 1 drop 3 times per day for 7 days.

Contraindications

None.

Adverse Reactions

Most common adverse reactions reported in patients were blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%).

Mechanism of Action

ZIRGAN is an antiviral drug [ see Microbiology (12.4)] .

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.